Cargando…
Topical Imiquimod 5% as a Treatment Option in Solitary Facial Keratoacanthoma
BACKGROUND: Keratoacanthoma (KA) is a rapidly growing epithelial tumour with histopathologic and clinical features similar to squamous cell carcinoma (SCC) and a certain tendency toward spontaneous regression. CASE PRESENTATION: This article presents a unique and rare case of keratoacanthoma arising...
Autores principales: | Pancevski, Goran, Pepic, Senada, Idoska, Sanela, Tofoski, Gligor, Nikolovska, Suzana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Republic of Macedonia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874379/ https://www.ncbi.nlm.nih.gov/pubmed/29610614 http://dx.doi.org/10.3889/oamjms.2018.133 |
Ejemplares similares
-
Successful treatment of a keratoacanthoma in a young patient with the application of topical 5% imiquimod cream
por: Plachouri, Kerasia‐Maria, et al.
Publicado: (2021) -
Treatment of Keratoacanthoma with 5% Imiquimod Cream and Review of the Previous Report
por: Jeon, Hye Chan, et al.
Publicado: (2011) -
Dermatoscopy of Solitary Keratoacanthoma
por: Tandel, Jinal J., et al.
Publicado: (2022) -
Cryosurgery, Intralesional Methotrexate and Imiquimod for Keratoacanthoma: Tuning the Combination
por: Gaitanis, Georgios, et al.
Publicado: (2019) -
Solitary Palmar Keratoacanthoma: Case Report
por: Girijala, Raghavendra L, et al.
Publicado: (2018)